^
    Back
    Association details:
    Biomarker:AEBP1 overexpression
    Cancer:Glioma
    Drug:temozolomide (DNA synthesis inhibitor)
    Direction:Resistant
    Evidence:
    Evidence Level:
    Resistant: C3 – Early Trials
    Source:
    Biomed Res Int
    Title:

    Molecular Characterization of AEBP1 at Transcriptional Level in Glioma

    Published date:
    07/31/2021
    Excerpt:
    AEBP1 was overexpressed in GSCs and TMZ resistance cells...The survival analysis showed that the overexpressed level of AEBP1 was correlated with short survival time in both glioma and GBM patients.
    DOI:
    10.1155/2021/5579359